Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.

Menon, Venu

Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy. [electronic resource] - Journal of the American Heart Association 01 2020 - e014328 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

2047-9980

10.1161/JAHA.119.014328 doi


Aged
Biomarkers--blood
Blood Glucose--drug effects
Cardiovascular Diseases--mortality
Diabetes Mellitus, Type 2--blood
Double-Blind Method
Female
Glycated Hemoglobin--metabolism
Glycemic Control
Heart Disease Risk Factors
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use
Hypoglycemic Agents--therapeutic use
Male
Middle Aged
Predictive Value of Tests
Prospective Studies
Risk Assessment
Time Factors
Treatment Outcome